Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA.
Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway.
Chromogranin A levels have been correlated with survival and prognosis in patients with metastatic gut neuroendocrine tumors.
Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors.
We are pleased to see the consistent clinical results yielded by the EDI Chromogranin A ELISA Kit in this study.
We are happy that our chromogranin A kit played a role in the establishment of these results.
7 August 2014 - A study, carried out by Chinese researchers and published today in BMC Endocrine Disorders, has demonstrated that Chromogranin A
(CgA) is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumours (PNETs) but not for insulinomas.
The clinical relevance of chromogranin A as a biomarker for gastroentero-pancreatic neuroendocrine tumors.
Measurements of chromogranin B can serve as a complement to chromogranin A.
Immunohistochemical findings included positive staining with synaptophysin and CD56 (NCAM) and weak staining with chromogranin A
and CAM 5.
To evaluate the chromatographic separation of labeled and nonlabeled peptides, 1 mL of the monoiodinated peak fraction was mixed with 10 pmol of the relevant synthetic tyrosine-extended chromogranin A fragment and reapplied to the HPLC column as described.
Secretion of chromogranin A by peptide producing endocrine neoplasms.